ife AfTER COVID-19 (LATER-19): a prospective, longitudinal, cohort study of symptoms, physical function and psychological outcomes in a Western Australian population

South Metropolitan Health Service0 个研究点目标入组 344 人开始时间: 2021年8月13日最近更新: 2021年11月1日

试验速览

暂无简介。

•Participant inclusion criteria:
•Patients were eligible to participate if they are: (i) >= 18 years old, (ii) attended the recruitment sites with a confirmed or suspected diagnosis of COVID-19, and (iii) were recruited into or data is captured as per waiver of consent provisions in the ISARIC / WHO study (RGS3976). Hospitalised patients who did not consent to the ISARIC / WHO study were eligible for recruitment to the LATER-19 trial and were offered the opportunity to consent using the appropriate documents at time of recruitment or immediately prior to first assessment (in person or remote via video conference).

•Participant exclusion criteria:
•Participants were excluded with preexisting neuromuscular disorders thought to affect the measures of physical function including previous cerebrovascular incidents, muscle or bony injury within the last three months, or pre-existing disorders such as Parkinson’s Disease; preexisting mental illness,; and, significant communication or cognitive impairment thought to affect responses to self-report measures.

发起方